Goldman Sachs says watch these 5 warnings from the dot-com bubble to know if the AI craze is peaking

The stock market flashed five warning signs before the dot-com bubble popped in the early 2000s, strategists at Goldman Sachs ...

Puma Biotechnology: Step By Step In Making A Transition

Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.

1 Under-the-Radar AI Stock That Looks Like a Screaming Buy Right Now

Amplitude reported 18% revenue growth in the third quarter to $88.6 million, well ahead of the consensus at $86.3 million. On ...